TRANSITION SERVICES AGREEMENT IDENIX PHARMACEUTICALS, INC., IDENIX (CAYMAN) LIMITED NOVARTIS PHARMA AGTransition Services Agreement • November 8th, 2007 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
This Transition Services Agreement (“Transition Agreement”) is made as of 28 September 2007 between Idenix Pharmaceuticals, Inc. of 60 Hampshire Street, Cambridge, Massachusetts 02139, USA (“Idenix U.S.”), Idenix (Cayman) Limited c/o Walkers SPV Limited, Walker House, Mary Street, George Town, Grand Cayman, Cayman Islands (“Idenix Cayman” and, together with Idenix U.S., “Idenix”), and Novartis Pharma AG of Forum 1, Novartis Campus, 4056 Basel, Switzerland (“Novartis”).
AMENDMENT NO. 4 TO DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT IDENIX PHARMACEUTICALS, INC. IDENIX (CAYMAN) LIMITED NOVARTIS PHARMA AGDevelopment, License and Commercialization Agreement • November 8th, 2007 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations
